Clinical Trials Directory

Trials / Completed

CompletedNCT03421145

A Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

A Prospective, Randomized, Blinded, Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

Status
Completed
Phase
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Solventum US LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Rinse contains an anti-plaque agent that helps prevent the accumulation of dental plaque associated with gingivitis.

Detailed description

This is a prospective, single site, randomized, parallel, blinded clinical trial. Subjects will be randomly assigned to one of four treatment groups identified as Product A, Product B, Product C or Product D. Subjects will be screened for eligibility and entered into a washout period that is at least 7 days, during which time they will be provided with study toothbrush, toothpaste and dental floss. No oral rinses or medication that alters oral tissue health will be used or taken during the washout period. After randomization, the designated rinse will be placed into a non-transparent container so that other subjects and clinical examiners do not see the allocated rinse per the randomization schedule. Examinations for the clinical endpoints (PI, GI and BI) will be conducted at the baseline, 3-month, and 6-month visits. Interim visits will be scheduled to review diary, replenish study supplies, check study compliance, etc. Subjects will be provided Colgate Regular toothpaste, dental floss and a soft toothbrush (replaced at 3 months) for use during the 6-month study period.

Conditions

Interventions

TypeNameDescription
DEVICE3M™ Oral RinseThe Investigational Rinse contains a sugar-based surfactant using a proprietary formula. The intended use of the product is to help prevent and reduce plaque accumulation on the teeth and related gum-tissue inflammation (gingivitis).
OTHERVehicle Control Oral RinseThe Placebo Comparator oral rinse is similar to the Experimental Oral Rinse only it does not contain the active ingredient.
DEVICEPerioShield™ Oral Health RinsePerioShield™ Oral Health Rinse (0.2% delmopinol hydrochloride) is marketed in the US and was purchased for use in this study.
OTHERWaterPurified bottled water containing no active ingredients.

Timeline

Start date
2017-12-17
Primary completion
2019-01-17
Completion
2019-01-17
First posted
2018-02-05
Last updated
2024-10-01
Results posted
2023-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03421145. Inclusion in this directory is not an endorsement.